Abbott
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
Business & Industry
- The Bristol-Myers Squibb-Pfizer Alliance and Fitbit collaborate to address gaps in atrial fibrillation detection with the aim of accelerating diagnosis
- Trastuzumab deruxtecan granted FDA Priority Review for treatment of patients with HER2-positive metastatic breast cancer
- Novartis announces that Jakavi® (ruxolitinib) meets primary endpoint in Phase III study of acute graft-versus-host disease
- Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing
- Abbott and Omada Health partner to offer integrated digital health and coaching experience for people with Type 2 diabetes
Research & Development
- New strategy to treat Parkinson's disease
- AI could offer warnings about serious side effects of drug-drug interactions
- Antibody-based eye drops show promise for treating dry eye disease
- Powerful new genomics method can be used to reveal the causes of rare genetic diseases
- AI and big data predict which research will influence future medical treatments
- Pharmacists provide patient value in team-based care
- Cancer patients who exercise have less heart damage from chemotherapy
Conferences & Events
- SMi's 9th Annual Orphan Drugs & Rare Diseases Conference
- SMi's Inaugural Pharmaceutical Manufacturing & Cleanroom Technology Conference
- Disruptive Technologies in Pharma 2019
- Respiratory Drug Delivery 2019
- Exclusive iVeena speaker interview released for 3rd Ophthalmic Drugs Conference
- eyeforpharma The Marketing Disruption Summit
- Optima to host post-conference workshop at Lyophilization USA
Regulatory Affairs
- FDA approves new treatment for patients with migraine
- FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
- FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
- FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
- FDA approves first oral GLP-1 treatment for type 2 diabetes